Cargando…

ETMM-02. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA

Metabolic reprogramming is a hallmark of cancer, and malignant cells must acquire metabolic adaptations in response to a multitude of intrinsic and extrinsic factors to fuel neoplastic progression. Mutations or changes in metabolic gene expression can impose nutrient dependencies in tumors, and even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minami, Jenna, Bayley, Nicholas, Tse, Christopher, Zhu, Henan, Morrow, Danielle, Yong, William, Liau, Linda, Cloughesy, Timothy F, Graeber, Thomas, Nathanson, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992209/ http://dx.doi.org/10.1093/noajnl/vdab024.058

Ejemplares similares

DDRE-23. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO LIPID PEROXIDATION INDUCED CELL DEATH
por: Morrow, Danielle, et al.
Publicado: (2021)

DIPG-55. DIRECT BRAIN-TO-BRAIN WORKFLOW ENABLES THE PRECLINICAL MODELING OF PEDIATRIC GLIOMAS
por: Tum, Hong, et al.
Publicado: (2023)

ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
por: Garcia, Joseph H, et al.
Publicado: (2021)

DIPG-56. PEDIATRIC GLIOMAS EXHIBIT A UNIQUE LIPID METABOLIC PHENOTYPE DISTINCT FROM ADULT GBMS
por: Salinas, Jennifer, et al.
Publicado: (2023)

ETMM-05. LACTIC ACID FACILITATES GLIOBLASTOMA GROWTH THROUGH MODULATION OF THE EPIGENOME
por: Torrini, Consuelo, et al.
Publicado: (2021)

ETMM-07. HYPOXIC REGULATION OF METABOLIC AND STRUCTURAL GENES IN T98 GLIOBLASTOMA MULTIFORME CELLS BY RNA SEQUENCING
por: White, Brian E, et al.
Publicado: (2021)

ETMM-01. CANCER STEM CELL ENRICHMENT AND METABOLIC SUBSTRATE ADAPTABILITY ARE DRIVEN BY HYDROGEN SULFIDE SUPPRESSION IN GLIOBLASTOMA
por: Silver, Daniel J, et al.
Publicado: (2021)

ETMM-04. AURKA INHIBITION REPROGRAMS METABOLISM AND IS SYNTHETICALLY LETHAL WITH FATTY ACID OXIDATION INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS
por: Nguyen, Trang, et al.
Publicado: (2021)

ETMM-08 METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
por: Kumar, Sachin, et al.
Publicado: (2021)

ETMM-03. CANCER CELLS DEPLOY LIPOCALIN- 2 TO COLLECT LIMITING IRON IN LEPTOMENINGEAL METASTASIS
por: Chi, Yudan, et al.
Publicado: (2021)

ETMM-06. ELEVATED MITOCHONDRIAL TOM20 EXPRESSION SUPPRESSES GLIOMA MALIGNANCY BY ENHANCING OXIDATIVE PHOSPHORYLATION
por: Li, Mao, et al.
Publicado: (2021)

BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
por: Ellingson, Benjamin, et al.
Publicado: (2021)

FSMP-02. CHANGES IN GLUTAMINE METABOLISM INDUCED BY OXALOACETATE IN GLIOBLASTOMA
por: Ijare, Omkar, et al.
Publicado: (2021)

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application
por: Funakoshi, Yusuke, et al.
Publicado: (2020)

BIMG-17. EFFECTS OF THE TUMOUR MICROENVIRONMENT ON PROTOPORPHYRIN IX ACCUMULATION IN GLIOBLASTOMA
por: Walker, Paul, et al.
Publicado: (2021)

OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021)

OTME-2. Regulation of chromatin accessibility in the hypoxic tumor microenvironment of glioblastoma
por: Dzwigonska, Monika, et al.
Publicado: (2021)

NEIM-02 DEVELOPMENT OF A DEEP LEARNING MODEL FOR DISCRIMINATING TRUE PROGRESSION FROM PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
por: Moassefi, Mana, et al.
Publicado: (2022)

CLRM-02 SINGLE CENTER EXPERIENCE OF DOPAMINE ANTAGONIST ONC-201 FOR RECURRENT H3K27M-MUTANT GLIOBLASTOMA IN ADULTS
por: Ekhator, Chukwuyem, et al.
Publicado: (2022)

ANGI-1 Impact of neoadjuvant bevacizumab on transcriptional factor for stemness, macrophage polarization, and oxygenation of tumor microenvironment in glioblastoma
por: Tanaka, Toshihide, et al.
Publicado: (2021)

DDRE-06. REGULATION OF TUMOR MICROENVIRONMENT VIA ENDOTHELIAL-TO-MESENCHYMAL TRANSITION BLOCKADE IN GLIOBLASTOMA-ASSOCIATED BRAIN ENDOTHELIAL CELLS
por: Marin’ Ramos, Nagore I, et al.
Publicado: (2021)

Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma
por: Patel, Kunal S., et al.
Publicado: (2020)

OTME-20. Chitinase-3-like-1(CHI3L1) Protein Complexes Regulate the immunosuppressive Microenvironment in Glioblastoma
por: Chen, Apeng, et al.
Publicado: (2021)

STMO-02 Efficacy of preoperative embolization for hemangioblastoma
por: Hiu, Takeshi, et al.
Publicado: (2020)

Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab
por: Patel, Kunal S, et al.
Publicado: (2020)

Microbiology and Preclinical Review of Omadacycline
por: Karlowsky, James A, et al.
Publicado: (2019)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma
por: Nagane, Motoo, et al.
Publicado: (2020)

COT-02 The opening of tumor treating fields with online support system
por: Sadahiro, Hirokazu, et al.
Publicado: (2020)

BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
por: Mansouri, Alireza, et al.
Publicado: (2022)

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
por: Lee, Alexander H., et al.
Publicado: (2021)

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
por: Lee, Yohan, et al.
Publicado: (2008)

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone
por: Kappadakunnel, Melanie, et al.
Publicado: (2009)

OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors
por: Shah, Khalid, et al.
Publicado: (2021)

TB-02 Comprehensive analysis of expandable benign pituitary adenomas without genetic manipulations
por: Yokogami, Kiyotaka, et al.
Publicado: (2020)

BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
por: Zhu, Lucía, et al.
Publicado: (2021)

SPCR-02 NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LEPTOMENINGEAL METASTASIS TREATED WITH PROTON CRANIOSPINAL IRRADIATION
por: Correa, Denise, et al.
Publicado: (2022)

ECG Dispersion Mapping in Preclinical Diagnosis of Cardiovascular Diseases
por: Esina, E.Yu., et al.
Publicado: (2020)

LMD-02. Cerebrospinal Fluid Diversion for Metastatic Leptomeningeal Carcinomatosis: Palliative, Procedural and Oncologic Outcomes
por: Bander, Evan D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cqh1ihgpsu1napvlfib0q5lesj